Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Decoy Therapeutics Inc DCOY

Healthcare Biotechnology
Decoy Therapeutics Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing. Its IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, optimize, and manufacture... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:DCOY)

Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics

GlobeNewswire January 7, 2026

Salarius Pharmaceuticals Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting

GlobeNewswire December 19, 2025

Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform

GlobeNewswire December 18, 2025

Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study

GlobeNewswire December 1, 2025

Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol "SLRX"

GlobeNewswire November 19, 2025

Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger

GlobeNewswire November 13, 2025

Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering

PR Newswire November 11, 2025

Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements

GlobeNewswire October 13, 2025

Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire September 9, 2025
View More News ››

Opinion & Analysis (NDAQ:DCOY)

Seven biotech names on the upswing: 2016 small-cap biotech watchlist update

The Life Sciences Report March 11, 2016
View More Opinion ››

Bullboard Posts (NDAQ:DCOY)

SLRX....You can't believe anything these Maddapakkas say or

File.............F me !!!!!
Iseneschal - November 13, 2025

RE:SLRX....In addition, The Merger with Decoy will be voted on

I read that the merger still had to be voted on at the next meeting......WTF!!!!Now they put this NR out....F'king Maddapakkas !!!!...
Iseneschal - November 13, 2025

SLRX....LMFBO.....NR

  Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger    
Iseneschal - November 13, 2025

SLRX....These MM's never lose....they have such deep pockets

supporting their cause....I call them "Hired Assassins" They thrive on Human Emotion....Greed & Fear.....They will lure...
Iseneschal - November 12, 2025

RE:SLRX....just keep drinking the Kool-Aide Folks....

Well well well ....would you just look at that Rug Pull.....LMFBO ! Straight down to $1.225 from the recent high of $1.40....now...
Iseneschal - November 12, 2025

SLRX....just keep drinking the Kool-Aide Folks....

the End is Neigh ; ) $1.275
Iseneschal - November 12, 2025
View more Bullboard ››

BioVaxys Technology Corp.

BioVaxys Technology Corp.

BioVaxys Technology Corp., a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms ...
View More »

Podcasts